Acute Tubular Necrosis Associated with Angiotensin Receptor-neprilysin Inhibitor

Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), significantly reduces mortality and morbidity in patients with chronic heart failure with a reduced ejection fraction (HFrEF). However, a considerable number of patients treated with sacubitril/valsartan experience hypotensio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Moo Jun, Jang, Ha Nee, Song, Haa-Na, Lee, Jong Sil, Kang, Min Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177371/
https://www.ncbi.nlm.nih.gov/pubmed/34707049
http://dx.doi.org/10.2169/internalmedicine.8373-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177371/
https://www.ncbi.nlm.nih.gov/pubmed/34707049
http://dx.doi.org/10.2169/internalmedicine.8373-21

Ejemplares similares